A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
about
The detection, treatment, and biology of epithelial ovarian cancerCharacterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodiesImpact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal womenGenetic identity and differential expression of p38.5 (Haymaker) in human malignant and nonmalignant cellsMolecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancersIdentification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresisMathematical model identifies blood biomarker-based early cancer detection strategies and limitationsPelvic mass associated with raised CA 125 for benign condition: a case reportMucins in cancer: function, prognosis and therapyBeyond CA125: the coming of age of ovarian cancer biomarkersMesothelin targeted cancer immunotherapyA binding domain on mesothelin for CA125/MUC16Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumorsGlycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsEpithelioid Sarcoma: Opportunities for Biology-Driven Targeted TherapyDeciphering the molecular nature of ovarian cancer biomarker CA125Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelinExpression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor InvasionMethylation of cell-free circulating DNA in the diagnosis of cancerNBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tubeThe APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesisExpression of CA125 and cisplatin susceptibility of pleural effusion-derived human lung cancer cells from a Thai patientA multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasMUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouseGenome-scale screen for DNA methylation-based detection markers for ovarian cancerUltrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function.The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.A note from history: Landmarks in history of cancer, part 7.Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.Progress and challenges in screening for early detection of ovarian cancer.SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.Characterization of serum biomarkers for detection of early stage ovarian cancer.Systematic evaluation of candidate blood markers for detecting ovarian cancer.TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patientsMucins in ovarian cancer diagnosis and therapyQuantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor b signaling pathwayThe biology of ovarian cancer: new opportunities for translationA novel high-affinity human monoclonal antibody to mesothelin.
P2860
Q21198791-E4ACB281-9578-499A-9B5A-371423634F57Q21198792-25A0DB59-B60F-499C-9A8D-65A0717DECB8Q24195062-D7675276-B8DC-43EB-B9B9-A31C17CE861EQ24292037-7C1C92BC-C005-4952-B3FC-3CFEB4399D89Q24315965-7C7CBCB0-D5D4-4611-B9A9-CA42531F9080Q24600418-5666AC56-6568-43A9-8478-951B224031E2Q24614865-DACB5453-BB2A-4459-851C-C4CCED49E23AQ24630815-8DE95C6F-F2A6-4C77-A29C-6497BAEE1D22Q24633765-88DD8F05-4222-4DFB-9453-8E35ED150EEEQ24651567-51B44689-E93F-4E8A-8F9B-10D5EC4C3CB3Q24656242-052A8A08-7A9C-4990-AC63-7B40F43F89D9Q24658397-3C93B5CF-60A3-4509-8FC2-2D52F8794CFEQ24673454-3268C6C8-4971-43A1-99C0-D5C13100F492Q26778227-E0532635-DF02-4A86-BC5A-DAC182219DBBQ26782730-2FF1072A-1CAD-4E4B-9C00-3B281A329794Q27015008-10D8CF84-70FC-49BD-B630-B5EB080787CBQ27015134-F41DBDA4-21B7-4638-BAAA-B99250C71AAFQ27307193-D018B091-0BB0-48C4-BF7C-5C70AB47E900Q28085699-4045FFE6-55D9-48F2-A111-3CB17FFC584BQ28202584-FF8BA90E-EC9E-4D3A-B60B-4DDF05036568Q28255263-F78CD47A-3E1A-41ED-8EDA-A4B088220A6CQ28386717-E0DE5FE0-241F-400C-8854-52B132A46652Q28392105-730E0BA6-CBCA-4085-905B-17B13132B4B3Q28594087-C31332E4-A2FB-4395-9CB3-19A66C66184BQ28741759-351EE6F7-10DF-4D61-8B7F-E38918DEBCD2Q30398174-BCD860D3-0897-463E-9F5E-4DF34D564F3FQ30405874-38AC38DF-FB47-4725-AB1B-2B124ADD1652Q30651522-9D295E30-2DEF-4A15-9B6E-02F6FD9676CFQ30740899-7C45CF5C-487A-4519-8455-B427541AD6ABQ30931923-97ECBD4A-7769-4436-9334-650892AC8BF2Q31005059-61A9439E-CFC2-4AC0-A05F-588CA5ABCF11Q31041170-B4EA9933-5A8F-4A04-8491-90FB9FDB0BE1Q33222839-CEADB120-F5C9-4F4C-B8D2-6AA811A0064BQ33225572-B85B98D3-54AA-4625-ADF4-32258E3E7103Q33350146-E6F9B87A-8753-4774-A2CD-D74F7E574FDEQ33553922-FBA3F975-D46A-48CA-B406-9A61DA382EF3Q33583166-806529BE-DBEE-4D37-A79E-8791470408BFQ33591805-56A188D4-CA9E-4642-A163-4859052D0252Q33622369-CCFC4C8F-7820-4793-885A-1D2C25D273C1Q33634221-D502F981-8096-4A09-9FF8-9B66898AA416
P2860
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
description
1983 nî lūn-bûn
@nan
1983 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@ast
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@en
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@nl
type
label
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@ast
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@en
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@nl
prefLabel
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@ast
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@en
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@nl
P2093
P1476
A radioimmunoassay using a mon ...... of epithelial ovarian cancer.
@en
P2093
Bast RC Jr
Berkowitz RS
Griffiths CT
P304
P356
10.1056/NEJM198310133091503
P407
P577
1983-10-01T00:00:00Z